Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference
February 15 2017 - 5:29PM
Business Wire
Biogen Inc. (NASDAQ: BIIB) announced today that it will present
at the 2017 RBC Capital Markets Global Healthcare Conference. The
webcast will be live on Wednesday, February 22, 2017 at 3:05 p.m.
EST. To access the live webcast, please visit Biogen’s
Investors section at www.biogen.com/investors. An archived version
of the webcast will be available following the presentation.
About BiogenThrough cutting-edge science and medicine,
Biogen discovers, develops and delivers worldwide innovative
therapies for people living with serious neurological and
neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in
biotechnology and today the Company has the leading portfolio of
medicines to treat multiple sclerosis, has introduced the first and
only approved treatment for spinal muscular atrophy, and is at the
forefront of neurology research for conditions including
Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral
sclerosis (ALS). Building on its heritage in biologics, Biogen also
manufactures and commercializes high-quality biosimilars. For more
information, please visit www.biogen.com. Follow us on social media
– Twitter, LinkedIn, Facebook, YouTube.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170215006358/en/
BiogenKaren Jewell, 781-464-2442Investor Relations
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2023 to Apr 2024